NCT05659797View on ClinicalTrials.gov

FES BPET-DBT in Newly Diagnosed Breast Cancer

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 2, 2023

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions
Breast Cancer
Interventions
DEVICE

BPET/DBT imaging

Imaging of the breast with a novel device combining dedicated Breast Positron Emission Tomography (BPET) and Digital Breast Tomosynthesis (DBT) following intravenous injection of \[18F\]-Fluoroestradiol (FES).

DRUG

18F-FES

Radiolabelled fluoroestradiol for PET imaging

Trial Locations (1)

19130

RECRUITING

University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

Abramson Cancer Center at Penn Medicine

OTHER